Friedrich Asmus

Friedrich Asmus, MD, serves as Chief Development Officer (Consultant) at Pykus Therapeutics and Chief Executive Officer at Ocular Clinical Consulting GmbH, providing expertise in translational and clinical stage development for ophthalmology and related fields since January 2025. As a Private Lecturer of Neurology at University Hospital of Tübingen since May 2011, Friedrich focuses on General Neurology and Neurodegenerative Diseases. Prior roles include Chief Medical Officer at Oxular, Senior Vice President of Clinical Development and Medical Affairs at jCyte, Vice President of Clinical Development at ProQR Therapeutics, and Global Clinical Leader in Ophthalmology at Bayer Pharmaceuticals. A strong background in neurology is complemented by experience at the Hospital of the University of Tübingen, with significant involvement in clinical trials and research on neurodegenerative diseases and related therapies. Educational qualifications include a Doctor of Medicine (MD) from Ludwig-Maximilians-University, Munich.